\n\n\n\n\t\t\n\t\t\tESTECH\n\t\t\thttp://www.estechlics.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tEndoscopic Technologies (ESTECH), is a medical device company focused on the development and sale of products for use in minimally invasive cardiovascular surgery procedures. ESTECH\u2019s tools enable...More»
\n\t\t\tEndoscopic Technologies (ESTECH), is a medical device company focused on the development and sale of products for use in minimally invasive cardiovascular surgery procedures. ESTECH\u2019s tools enable surgeons to perform coronary artery bypass surgery (CABG) on a beating heart in order to avoid the use of heart-lung machines, which are known to increase the risk of stroke as a surgical complication. The Company\u2019s products also enable CABG surgery to be performed without a sternotomy, where the patient has an 8\u201d-12\u201d opening in the chest cavity; ESTECH\u2019s surgeries, in contrast, are typically performed through 2\u201d surgical openings, resulting in shorter hospital stays, less pain, and significantly fewer complications for patients with coronary artery disease.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tSan Ramon, CA, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\tdevelopment,\n\t\t\t\testech,\n\t\t\t\tsale,\n\t\t\t\tendoscopic technologies,\n\t\t\t\tfocused,\n\t\t\t\tsurgeries,\n\t\t\t\theart-lung\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series B - $5M (08/12/2003)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tPsilos Group Management,\n\t\t\t\t\t\n\t\tTelegraph Hill Partners,\n\t\t\t\t\t\n\t\tBoston Scientific\n\t\t\t\t
\n\t\t\t